BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6838419)

  • 1. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
    Grimson BS; Bowman ZL
    Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective management of a suprasellar extending prolactinoma during pregnancy.
    Pittini L; Minisci N; Negri P
    Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
    Robbins RJ; Kern PA; Thompson TL
    Am J Med; 1984 May; 76(5):921-3. PubMed ID: 6720732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual function in prolactinoma patients treated with bromocriptine.
    Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
    Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine reduction of prolactinoma size.
    Corenblum B; Hanley DA
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
    Landolt AM; Minder H; Osterwalder V; Landolt TA
    Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size reduction of a large prolactinoma by bromocriptine treatment. Report of a case.
    Matsumura S; Mori S; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):127-30. PubMed ID: 6168944
    [No Abstract]   [Full Text] [Related]  

  • 9. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
    Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical treatment of the hypersecreting pituitary gland.
    Corenblum B
    Can J Neurol Sci; 1985 Aug; 12(3):243-50. PubMed ID: 2996735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic treatment of nonfunctioning pituitary adenomas.
    Greenman Y
    Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):554-5. PubMed ID: 17579584
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J; Sato O; Tanabe S
    Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
    Ayers JW
    Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
    Lengyel AM; Mussio W; Imamura P; Vieira JG; Lancranjan I
    Fertil Steril; 1993 May; 59(5):980-7. PubMed ID: 8486199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES; García IC; Ruíz JE; Zárate A
    Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.